409 related articles for article (PubMed ID: 8706747)
21. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
22. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
Munro AW; Daff SN; Turner KL; Chapman SK
Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
[No Abstract] [Full Text] [Related]
23. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
Gonvindaraj S; Li H; Poulos TL
Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
[TBL] [Abstract][Full Text] [Related]
24. Structural and enzymological analysis of the interaction of isolated domains of cytochrome P-450 BM3.
Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
FEBS Lett; 1994 Apr; 343(1):70-4. PubMed ID: 8163021
[TBL] [Abstract][Full Text] [Related]
25. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds.
Oliver CF; Modi S; Primrose WU; Lian LY; Roberts GC
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):537-44. PubMed ID: 9359427
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of flavin reoxidation in P450 BM3 by diphenyliodonium chloride.
Munro AW; Coggins JR; Lindsay JG
Biochem Soc Trans; 1996 Feb; 24(1):17S. PubMed ID: 8674653
[No Abstract] [Full Text] [Related]
27. Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity.
Modi S; Primrose WU; Lian LY; Roberts GC
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):939-43. PubMed ID: 7575430
[TBL] [Abstract][Full Text] [Related]
28. Functional interactions in cytochrome P450BM3. Evidence that NADP(H) binding controls redox potentials of the flavin cofactors.
Murataliev MB; Feyereisen R
Biochemistry; 2000 Oct; 39(41):12699-707. PubMed ID: 11027150
[TBL] [Abstract][Full Text] [Related]
29. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
30. NADPH oxidase activity of cytochrome P-450 BM3 and its constituent reductase domain.
Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
Biochim Biophys Acta; 1995 Oct; 1231(3):255-64. PubMed ID: 7578214
[TBL] [Abstract][Full Text] [Related]
31. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
Neeli R; Roitel O; Scrutton NS; Munro AW
J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3).
Li H; Poulos TL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):141-9. PubMed ID: 10570242
[TBL] [Abstract][Full Text] [Related]
33. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
[TBL] [Abstract][Full Text] [Related]
34. Coding nucleotide, 5' regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase from Bacillus megaterium.
Ruettinger RT; Wen LP; Fulco AJ
J Biol Chem; 1989 Jul; 264(19):10987-95. PubMed ID: 2544578
[TBL] [Abstract][Full Text] [Related]
35. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
McLean KJ; Scrutton NS; Munro AW
Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197
[TBL] [Abstract][Full Text] [Related]
36. Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization.
Miles JS; Munro AW; Rospendowski BN; Smith WE; McKnight J; Thomson AJ
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):503-9. PubMed ID: 1334408
[TBL] [Abstract][Full Text] [Related]
37. A new approach to the study of protein-protein interaction by FTIR: complex formation between cytochrome P450BM-3 heme domain and FMN reductase domain.
Kariakin A; Davydov D; Peterson JA; Jung C
Biochemistry; 2002 Nov; 41(46):13514-25. PubMed ID: 12427012
[TBL] [Abstract][Full Text] [Related]
38. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
39. The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.
Munro AW; Malarkey K; McKnight J; Thomson AJ; Kelly SM; Price NC; Lindsay JG; Coggins JR; Miles JS
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):423-8. PubMed ID: 7980400
[TBL] [Abstract][Full Text] [Related]
40. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
